Uus ajastu HCV ravis – mis on muutunud
nature.com.ezproxy.utlib.ut.ee/articles/nrmicro3046.pdf (07.05.2018)
11. Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and
Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo, George
Koutsoudakis, Alexia Paris de León, Carolina Herrera et.al
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404530/ (07.05.2018)
12. Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection, Nezam
Afdhal, M.D., K. Rajender Reddy, M.D., David R. Nelson, M.D
https://www.nejm.org/doi/full/10.1056/NEJMoa1316366 (07.05.2018)
13. Joonis 2: https://en.wikipedia.org/wiki/Sofosbuvir/velpatasvir/voxilaprevir (11.05.2018)
10
14. Prevalence and impact of baseline resistance-associated substitutions on the efficacy of
ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection Gary P.
Wang, Norah Terrault, Jacqueline D. Reeves et.al
https://www
annaabi.ee 
